Comparison of the effect of sambiloto (AS 201-01) tablet and dihydroartemisinin-piperaquine on macrophage MIF expression in mice placenta infected with Plasmodium berghei
Downloads
Objective: To compare the administration of sambiloto tablets (AS201-01) and dihydroartemisinin-piperaquine phosphate tablets in pregnant mice infected by P. berghei on the expression of MIF in the placenta.
Materials and Methods: Experimental laboratory research, 24 pregnant mice were divided into 4 groups with randomization, ie. non-infected, placebo, sambiloto (AS201-01) and DHP groups. On day 9 P. berghei was infected, on day 11 the treatment was given, day 15 the surgery was performed, placental samples were taken, immunohistochemical staining was given, and MIF expression was assessed.
Results: The expression of MIF in the group not infected with P. berghei had the lowest mean, while the highest mean was found in the placebo group. Uninfected groups were not significantly different from sambiloto (AS201-01) tablet group. Sambiloto tablet group (AS201-01) had lower MIF expression than DHP group, but it was not significantly different. Sambiloto tablet group (AS201-01) showed lower MIF expression than placebo. MIF expression in DHP group was lower than that in placebo group. From the lowest, the MIF expressions were as follows: group not infected with P. berghei, group receiving sambiloto (AS201-01) tablet, DHP group and placebo group.
Conclusion: MIF expression in the placenta of pregnant mice infected with P. berghei and receiving sambiloto (AS20-01) tablets was not different from those receiving DHP tablets.
Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Kemenkes RI. 2017. Eliminasi Malaria Indonesia. http://eliminasi-malaria.blogspot. co.id/p/blogpage_43.html. 1 Mei 2017 (22.38).
Harijanto, PN. 2006. Buku Ajar Ilmu Penyakit Dalam. Jakarta: PIP FKUI; 1732-1744.
Nosten, F., McGready R., Mutabingwa T. 2007. Case Management of Malaria in Pregnancy. http//infection.thelancet.
com. 12 April 2017. (12.35).
Abbas, AK, Lichtman AH, Pober JS. 2000. Cellular and molecular immunology 4th ed. WB Saunders Co, 235-269. Philadelphia
Sharma, L., Kaur, J. and Shukla, G., 2012. Role of oxidative stress and apoptosis in the placental pathology of Plasmodium berghei infected mice. PLoS One, 7(3), p.e32694.
Tracy, J.W., Webster L.T. 1996. Drugs Used in Chemotherapy of Protozoa Infections. Dalam: Hardman JG, Gilman AG, Limbird LE. Penyunting. Goodman & Gilman's. The Pharmacological Basis of Therapheutics. Edisi ke-9. New York: Mc Milan, h. 965-85.
Tjitra, E. 1996. Pengobatan Malaria. Majalah Kedokteran Indonesia. 24-32.
Baird, JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC. 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 44 (5): 547-52.
Cendranata, WO. 2012. Daya hambat ekstrak daun sambiloto (Andrographis paniculata) terhadap populasi bakteri pada ulser recurrent aphthous stomatitis. Jurnal PDGI;61(1):20-3.
Fryauff, DJ., Tuti S, Mardi A, Masbar S, Patipelohi R, Leksana B. 1998. Chloroquine-resistant Plasmodium Vivax in transmigration settlements of West Kalimantan, Indonesia. Am J Trop Med Hyg ;59(4):513-18.
Harijanto, P.N., Nugroho A, Gunawan CA., 2009, Malaria dari molekuler ke klinis ed 2, Jakarta. EGC. 2009; 118 – 194.
Nogueira, CR and lopes MLX. 2011. Antiplasmodial Natural Products. Molecules, 16:2146-2190.
Niramjan, A., Tewari SK, Lehri A. 2010. Biological activities of Kalmegh (Andrographis paniculata nees) and its active principles-a review. Indian J Natur prod Resources 1(2): 125-35.
Arcuri, F., Cintorino M, Vatti R. 2001. Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts.Biol Reprod 60(6): 1299–303.
Awandare, GA, Ouma Y, Ouma C. 2007. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun. 75 (1): 201–210.
Jain, V., Mc Clintock S., Nagpal AC. 2009. Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India. BMC Res Notes. 2: 36.
Singh, PP, Lucchi NW, Blackstock A. 2012. Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India. PLoS One 7(12): e51678.
Coutrier, F. 2008. Propagasi Malaria In Vivo: Penggunaan Hewan Coba Dalam Penelitian Malaria. Lembaga Biologi Molekul. Eijkman.
Otto, TD. 2014. A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biology 12: 86.
Juan, De Dios Rosado. 2011. Macrophage Migration Inhibitory Factor (MIF): A Key Player In Protozoan Infections. International Journal Of Biological Sciences 7(9): 1239 – 56.
Wickramasuriya, GAW. 1937. Clinical features of malaria in pregnancy. In: Wick-ramasuriya GAW, ed. Malaria and ankylostomiasis in the pregnant woman. Oxford University Press. London.
Fried, M., Nosten F, Brockman A, Brabin BJ, Duffy PE Nature. 1998. Maternal antibodies block malaria. In addition primiparous women have less antibodies to the CSA binding parasites that cause placental malaria 395(6705): 851-852.
An, H., H. Xu, Y. Yu, M. Zhang, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, Z. Qin, and X. Cao. 2002. Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunol Lett 81:165-169.
Arese, P., and E. Schwarzer. 1997. Malarial pigment (haemozoin): a very active 'inert' substance. Ann Trop Med Parasitol 91: 501-516.
Chaisavaneeyakorn, S., Lucchi N, Abramowsky C. 2005. Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas. Infect Immun. 73: 3287–93.
Neres, R., Marinho CR, Gonçalves LA, Catarino MB, Penha Gonçalves C. 2008. Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS One 3: e1608.
Brabin, BJ. 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61: 1005–16.
Barros, FC., Huttly SRA, Victora CG, Kirkwood BR, Vaughan JP. 1992. Comparison of the causes and consequences of prematurity and intrauterine growth retardation: longitudinal study in southern Brazil. Pediatrics 90: 238–44.
Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R. Research Article (New England Journal of Medicine) Four artemisinin-based treatments in African pregnant women with malaria. Malawi Medical Journal. 2016;28(3):139-49.
Widyawaruyanti A., Hafid AF., Tantular I. 2015. Aplikasi tablet fraksi EA Sambiloto (Adrographis paniculata Ness) sebagai terapi malaria. Laporan Pusat Unggulan Nasional, Dikti 2015.
Zein, U., Fitri LE, Saragih A. Comparative study of antimalarial effect of sambiloto (Andrographis paniculata) extract, chloroquine and artemisinin and their combination against Plasmodium falciparum in vitro. Acta Med Indones. 45(1): 38-43.
Jarukamjorn, K., and Nemoto N. 2008. Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide. J Health Science 54(4): 370-81.
Jaihan, U., Srichairatanakool S., Uthaipibull C., Somsak V. 2014. Antimalarial effects of methanolic leaf extract of andrographis paniculate on plasmodium berghei. J Health Res. 28 (6): 403-8.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
